Standout Papers

Ankylosing spondylitis 2002 2026 2010 2018 1.3k
  1. Ankylosing spondylitis (2007)
    Jürgen Braun, Joachim Sieper The Lancet
  2. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis (2009)
    Joachim Sieper, Martín Rudwaleit et al. Annals of the Rheumatic Diseases
  3. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general (2010)
    Martín Rudwaleit, D. van der Heijde et al. Annals of the Rheumatic Diseases
  4. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial (2002)
    Jürgen Braun, J. Brandt et al. The Lancet
  5. Axial spondyloarthritis (2017)
    Joachim Sieper, Denis Poddubnyy The Lancet
  6. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis (2015)
    Dominique Baeten, Joachim Sieper et al. New England Journal of Medicine
  7. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis (2008)
    Cédric Lukas, Robert Landewé et al. Annals of the Rheumatic Diseases
  8. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors (1998)
    J�rgen Braun, U. Eggens et al. Arthritis & Rheumatism
  9. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial (2006)
    Désirée van der Heijde, Alan Kivitz et al. Arthritis & Rheumatism
  10. Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) (2005)
    Désirée van der Heijde, Ben A. C. Dijkmans et al. Arthritis & Rheumatism
  11. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group (2009)
    Martín Rudwaleit, Anne Grethe Jurik et al. Annals of the Rheumatic Diseases
  12. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis (2008)
    Désirée van der Heijde, E. Lie et al. Annals of the Rheumatic Diseases
  13. Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial (2008)
    Robert D. Inman, John C. Davis et al. Arthritis & Rheumatism

Immediate Impact

4 by Nobel laureates 15 from Science/Nature 66 standout
Sub-graph 1 of 19

Citing Papers

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
2021 Standout

Works of Joachim Sieper being referenced

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
2018
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Joachim Sieper 31982 18240 10758 548 36.6k
Jürgen Braun 26677 14660 8814 575 30.7k
Maxime Dougados 18909 9126 6754 541 23.2k
Robert Landewé 19500 8483 6377 524 23.8k
Ben A. C. Dijkmans 17930 6125 6033 330 24.4k
Walter P. Maksymowych 13748 6707 4331 504 17.2k
Maxime Dougados 18362 6280 5277 392 24.1k
Martín Rudwaleit 16562 8734 5016 299 18.2k
Yoshiya Tanaka 14001 9387 5090 1.1k 29.3k
Frank C. Arnett 23969 9154 5579 196 37.1k
Xenofon Baraliakos 13547 7258 4492 570 15.3k

All Works

Loading papers...

Rankless by CCL
2026